News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries, source story ideas and download MSK digital assets.
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing.
"Get the Vaccine to Save Lives" aims to help Americans feel safe and confident about receiving a COVID-19 vaccine.
In the News
MSK held COVID-19 vaccine pop-up clinics at our Brooklyn Infusion Center and Ralph Lauren Center in Harlem.
Read about why Jae Park joined his colleagues at MSK and New York-Presbyterian to publicly show a united stance against hate.
TV anchor Al Roker discusses his own prostate cancer experiences, disparities in cancer care and outcomes for people of color, the importance of cancer screening for Black men, and more with Dr. Carol Brown, a gynecological oncology surgeon at Memorial Sloan Kettering and Nicholls-Biondi Chair for Health Equity at Memorial Sloan Kettering.
Stay Connected with MSK
News Releases
Dr. Sawyers is recognized for his dedication to cancer research, education, collaboration, science policy, advocacy, and funding.
In her new role, Dr. Hsu will work to diversify matriculating classes and train students to become skilled leaders as both clinicians and biomedical researchers.
Several MSK physicians and researchers presenting during the plenary sessions.
Media Coverage
It’s the fourth most-commonly diagnosed cancer for U.S. women. So, why aren’t we talking more about it? MSK’s Mario Leitao is quoted.
Tuesday, April 20, 2021
While multiple myeloma is a rare cancer, there are lots of resources available to support people who have it. A good place to start is your own care team. MSK’s Michelle O’Hare and Urvi Shah are quoted.
Tuesday, April 20, 2021
The cancellation of the New York State Stem Cell Science program (NYSTEM) is contained in a budget for 2022, which the state Legislature approved last week and Governor Andrew Cuomo signed. The spending plan, which takes effect 1 May, halts funding for new grants, but honors existing contracts until they expire. MSK’s Lorenz Studer is quoted.
Monday, April 19, 2021
News from the Lab
The DNA breaks that occur during meiosis are necessary but dangerous. Scientists now have a better handle on how cells control the chaos.
Meet molecular biologist Agnel Sfeir, who joined SKI's Molecular Biology Program in March 2021.
The [email protected] fellowship will provide Dr. Delconte with two years of financial support for her research on natural killer cells in cancer.
MSK News
Scientists at Memorial Sloan Kettering are learning how to turn cancer’s appetite against itself.
Learn about Verdun Perry’s devotion to fund rare cancer research at MSK.
The MSK Immigrant Health & Cancer Disparities service improves people’s lives in communities that too often get overlooked and suffer disproportionately from cancer, including lack of access to care.
2019 Annual Report: It Starts with One
A unique program at MSK Kids is dedicated to finding a cure for every child with cancer.
Researchers in the Sloan Kettering Institute conducted a far-reaching analysis of single cells that is changing how we think about development.
Liquid biopsies are shedding light on cancer DNA that’s hiding out in the bloodstream. MSK-ACCESS is one such test that took a big leap forward in 2019.